Clinical Trial

Periodontal Therapy and Genitourinary Inflammation in Patients With Prostatitis and Recurrent Urinary Tract Infections

Study acronym: PERIO-PSA
Completed
View on ClinicalTrials.gov →
Summary
This randomized controlled clinical trial evaluates the impact of non-surgical periodontal therapy on systemic inflammatory markers in patients with chronic prostatitis or recurrent urinary tract infections. Emerging evidence suggests a possible association between periodontal inflammation and genitourinary conditions. A total of 60 male participants diagnosed with periodontitis and either chronic prostatitis or recurrent urinary tract infections were randomly assigned to one of three groups: non-surgical periodontal therapy, oral hygiene instruction only, or no periodontal treatment. The primary outcomes were changes in serum prostate-specific antigen (PSA) levels and the frequency of positive urine cultures over a 120-day follow-up period. The study aims to investigate whether periodontal treatment may reduce systemic inflammatory burden and improve genitourinary clinical parameters.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-22.
Trial Details
NCT Number NCT07438184
Lead Sponsor University of Salamanca
Conditions Periodontitis, Chronic Prostatitis (CP), Urinary Tract Infections
Enrollment 60 participants
Start Date 2024-01-01
Primary Completion 2025-04-01 (estimated)
Study Completion 2025-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-13